Frontiers in Immunology (Sep 2017)

Phosphoproteomics Reveals Regulatory T Cell-Mediated DEF6 Dephosphorylation That Affects Cytokine Expression in Human Conventional T Cells

  • Rubin N. Joshi,
  • Nadine A. Binai,
  • Nadine A. Binai,
  • Francesco Marabita,
  • Zhenhua Sui,
  • Amnon Altman,
  • Albert J. R. Heck,
  • Albert J. R. Heck,
  • Jesper Tegnér,
  • Jesper Tegnér,
  • Jesper Tegnér,
  • Angelika Schmidt

DOI
https://doi.org/10.3389/fimmu.2017.01163
Journal volume & issue
Vol. 8

Abstract

Read online

Regulatory T cells (Tregs) control key events of immune tolerance, primarily by suppression of effector T cells. We previously revealed that Tregs rapidly suppress T cell receptor (TCR)-induced calcium store depletion in conventional CD4+CD25− T cells (Tcons) independently of IP3 levels, consequently inhibiting NFAT signaling and effector cytokine expression. Here, we study Treg suppression mechanisms through unbiased phosphoproteomics of primary human Tcons upon TCR stimulation and Treg-mediated suppression, respectively. Tregs induced a state of overall decreased phosphorylation as opposed to TCR stimulation. We discovered novel phosphosites (T595_S597) in the DEF6 (SLAT) protein that were phosphorylated upon TCR stimulation and conversely dephosphorylated upon coculture with Tregs. Mutation of these DEF6 phosphosites abrogated interaction of DEF6 with the IP3 receptor and affected NFAT activation and cytokine transcription in primary Tcons. This novel mechanism and phosphoproteomics data resource may aid in modifying sensitivity of Tcons to Treg-mediated suppression in autoimmune disease or cancer.

Keywords